Hongkai Bi

Title: Innovations of Hongkai Bi in Pharmaceutical Development

Introduction

Hongkai Bi is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of innovative compounds that have potential therapeutic applications. His work focuses on the development of zinc linolenate, a compound with promising effects against Helicobacter pylori.

Latest Patents

Hongkai Bi holds a patent for the "Preparation of zinc linolenate, and application of zinc linolenate in preparing anti-helicobacter pylori drug." This patent details a method for preparing zinc linolenate, which involves dissolving zinc chloride in sterile water, heating and activating the solution, and then cooling it to room temperature. The process includes the activation of linolenic acid in an EMS solvent under nitrogen gas, followed by a reaction with the activated zinc chloride. The resulting zinc linolenate is obtained through dialysis and vacuum freeze drying, achieving a high yield and effective inhibiting properties.

Career Highlights

Hongkai Bi is affiliated with Nanjing Medical University, where he conducts research and development in pharmaceutical sciences. His innovative approach to drug formulation has garnered attention in the scientific community, contributing to advancements in treatments for bacterial infections.

Collaborations

Hongkai Bi has collaborated with notable colleagues, including Yanqiang Huang and Xudong Hang. Their combined expertise enhances the research efforts at Nanjing Medical University, fostering an environment of innovation and discovery.

Conclusion

Hongkai Bi's work exemplifies the intersection of innovation and pharmaceutical development. His patent on zinc linolenate showcases his commitment to advancing medical science and improving therapeutic options for patients.